These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2275511)

  • 21. In pregnancy, corticotropin-releasing-factor in maternal blood and amniotic fluid correlates with the gestational age.
    Maser-Gluth C; Lorenz U; Vecsei P
    Horm Metab Res Suppl; 1987; 16():42-4. PubMed ID: 3502115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varying distribution of 6-azauridine within the mouse foetoplacental unit.
    Jelínek R; Seifertová M; Tykva R
    Folia Morphol (Praha); 1977; 25(4):387-95. PubMed ID: 924297
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep.
    Pérez R; Palma C; Núñez MJ; Cox J
    J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal-fetal pharmacokinetics: summary and future directions.
    Szeto HH
    NIDA Res Monogr; 1995; 154():203-17. PubMed ID: 8606745
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacodynamics in the maternal-fetal-placental unit.
    Rudolph AM
    NIDA Res Monogr; 1995; 154():163-74. PubMed ID: 8606743
    [No Abstract]   [Full Text] [Related]  

  • 27. Meperidine pharmacokinetics in the maternal-fetal unit.
    Szeto HH; Mann LI; Bhakthavathsalan A; Liu M; Inturrisi CE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):448-59. PubMed ID: 682125
    [No Abstract]   [Full Text] [Related]  

  • 28. The mechanisms and regulation of placental amino acid transport to the human foetus.
    Cleal JK; Lewis RM
    J Neuroendocrinol; 2008 Apr; 20(4):419-26. PubMed ID: 18266945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological changes during pregnancy and their implications for pharmacological treatment.
    Redmond GP
    Clin Invest Med; 1985; 8(4):317-22. PubMed ID: 4075616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid function in pregnancy - maternal-fetal relationship in health and disease.
    Sack J
    Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():170-6; discussion 176. PubMed ID: 16444155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug effects on embryo and fetus. 2. Diaplacental transport of drugs].
    Reinhardt D; Richter O
    Fortschr Med; 1981 Sep; 99(35):1394-8. PubMed ID: 7274943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of pharmacokinetic variables in reproductive and developmental toxicity.
    Neubert D
    Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease.
    Stallmach T; Hebisch G; Joller-Jemelka HI; Orban P; Schwaller J; Engelmann M
    Lab Invest; 1995 Sep; 73(3):384-92. PubMed ID: 7564271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolism of glucocorticoid hormones in the mother and fetus].
    Palladi GA; Poklitar' MG; Mukutsa EV
    Vopr Okhr Materin Det; 1975 Jul; 20(7):66-9. PubMed ID: 1220182
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on diffusion of chemotherapeutic agents in uterine muscle, foetus, placenta, amnion and amniotic fluid of pregnant rabbits. On dibekacin (DKB) and ampicillin (ABPC) (author's transl)].
    Takabatake H; Oda T; Shiina M; Satoh Y; Ohno T
    Jpn J Antibiot; 1978 Jun; 31(6):307-9. PubMed ID: 682366
    [No Abstract]   [Full Text] [Related]  

  • 36. Principles of Pharmacokinetics in the Pregnant Woman and Fetus.
    Ward RM; Varner MW
    Clin Perinatol; 2019 Jun; 46(2):383-398. PubMed ID: 31010566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of placental permeability for 9-H3-prostaglandin F2 alpha at different periods of pregnancy].
    Kiriushchenkov AP; Sheveleva GA; Pugacheva TN; Eleni EL
    Akush Ginekol (Mosk); 1979 Aug; (8):31-4. PubMed ID: 532884
    [No Abstract]   [Full Text] [Related]  

  • 38. Heavy metals and placental fetal-maternal barrier: a mini-review on the major concerns.
    Caserta D; Graziano A; Lo Monte G; Bordi G; Moscarini M
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2198-206. PubMed ID: 23893187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal-placental-fetal unit: unique problems of pharmacologic study.
    Ward RM
    Pediatr Clin North Am; 1989 Oct; 36(5):1075-88. PubMed ID: 2677936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins and organogenesis.
    Persaud TV
    Adv Prostaglandin Thromboxane Res; 1978; 4():139-56. PubMed ID: 645503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.